CCM
CLVS

Cadian Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Cadian Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,604
Closed -$729K – 93
2014
Q2 		$729K Sell
17,604
-23,296
-57% -$1.2M 0.02% 77
2014
Q1 		$2.83M Buy
+40,900
New +$3M 0.07% 78

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Cadian Capital Management's CLVS Position: Q3 2014 in Review

Cadian Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2014, closing a stake of 17,604 shares — an estimated $729K sold.

Cadian Capital Management first reported a position in CLVS in Q1 2014 and held it in 2 quarters. The position peaked at $2.83M in Q1 2014. 138 funds tracked by Wall St. Rank hold CLVS as of Q3 2014.

  • Cadian Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2014 after selling out during the quarter.
  • Cadian Capital Management sold 17,604 Clovis Oncology, Inc. shares in Q3 2014, an estimated $729K.
  • Cadian Capital Management first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 2 quarters.
  • Cadian Capital Management's Clovis Oncology, Inc. position peaked at $2.83M in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2014.

Based on Cadian Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.